BIOXYTRAN, INC (BIXT) › Operating IncomeBIOXYTRAN, INC (BIXT) — Operating IncomeAnnual figures by period end, from SEC filings.2010-12-31: -$329.0K2011-12-31: -$4.43M2012-12-31: -$2.29M2013-12-31: -$1.97M2014-12-31: -$1.28M2015-12-31: -$2.09M2016-12-31: -$671.3K2017-12-31: -$310.6K2018-12-31: -$215.1K2019-12-31: -$1.63M2020-12-31: -$1.27M2021-12-31: -$4.21M2022-12-31: -$2.44M2023-12-31: -$3.80M2024-12-31: -$2.22M2025-12-31: -$1.84M-$1.84M2010-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$1.84M—2026-04-15From 2025-01-012024-12-31-$2.22M—2026-04-15From 2024-01-012023-12-31-$3.80M—2025-04-03From 2023-01-012022-12-31-$2.44M—2025-01-13From 2022-01-012021-12-31-$4.21M—2023-03-31From 2021-01-012020-12-31-$1.27M—2022-04-11From 2020-01-012019-12-31-$1.63M—2021-04-09From 2019-01-012018-12-31-$215.1K—2020-03-18From 2018-01-012017-12-31-$310.6K—2018-04-02From 2017-01-012016-12-31-$671.3K—2018-04-02From 2016-01-012015-12-31-$2.09M—2017-03-31From 2015-01-012014-12-31-$1.28M—2016-09-20From 2014-01-012013-12-31-$1.97M—2015-04-10From 2013-01-012012-12-31-$2.29M—2014-04-14From 2012-01-012011-12-31-$4.43M—2013-04-15From 2011-01-012010-12-31-$329.0K—2012-12-31From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)